Skip to main content

Troy R. Nichols

Associate

[email protected]

+1.617.348.4833

Share:

Troy represents public and private companies in a broad range of transactions and corporate matters, with a particular focus on mergers and acquisitions and corporate governance.  He has extensive experience leading domestic and cross-border M&A transactions across a wide range of industries, including life sciences, med-tech, biotech, healthcare, technology and software, industrial and manufacturing, services, retail and consumer products, and financial services.

Troy was previously a private equity associate at a global law firm, where he primarily represented private equity sponsors, portfolio companies, and family offices. During law school, Troy clerked for the U.S. Attorney’s Office in the District of Columbia and the Honorable Nicholas E. Rattal in Prince George’s County’s Circuit Court.

Before attending law school, Troy worked in finance at a multinational investment bank and a financial services company, and was a record-holding swimmer at the University of Massachusetts Amherst.

Experience

Mergers & Acquisitions

Life Sciences / Med-Tech / Biotech / Healthcare

  • Philips Healthcare in a number of transactions, including:
    • Sale of its Emergency Care business, focusing on defibrillation and resuscitation technologies, to a platform of Bridgefield Capital, a U.S.-based investment firm; and
    • Acquisition of Capsule Technologies, a leading provider of medical device integration and data technologies for hospitals and healthcare organizations.
  • QIAGEN N.V., a leading provider of molecular testing solutions, in its acquisition of Parse Biosciences, a leading provider of instrument-free solutions for single-cell research.
  • Automated HealthCare Solutions, a portfolio company of Abry Partners and leading provider of technology enabled, medications claims processing solutions for physicians serving worker’s compensation patients, in its sale to Advanced Rx.
  • Standard BioTools (Nasdaq: LAB) in a number of transactions, including:
    • Stock-for-stock merger with SomaLogic (Nasdaq: SLGC); and
    • Acquisition of Sengenics, a leading proteomics company providing high-density protein arrays for the discovery and validation of autoantibody biomarkers.
  • Syncona (LON: SYNC) in its acquisitions of Applied Genetic Technologies Corporation (Nasdaq: AGTC).
  • F-star Therapeutics (Nasdaq: FSTX) in its sale to invoX Pharma, a subsidiary of Sino Biopharma Limited (HKEX 1177 HK). This transaction was the first completed sale of a U.S. publicly traded biotech company to a Chinese entity in over a decade.
  • Netsmart Technologies, a leading provider of healthcare Software as a Service (SaaS) technology and services solutions, in a number of transactions, including:
    • Acquisition of Remarkable Health, an industry-leading provider of artificial intelligence technology and software solutions for behavioral health, substance use and human services organizations;
    • Acquisition of the entity owning TheraOffice, an industry-leading practice management platform for physical therapy and rehabilitation practices;
    • Acquisition of GPM, a Software-as-a-Service technology and services company;
    • Acquisition of Tellus, a provider of electronic visit verification (EVV), mobile care delivery and claims processing technology; and
    • Acquisition of Quality In Real Time (QIRT), a post-acute health care consulting firm.
  • NanoView Biosciences, a developer of proprietary products that support research, translation and delivery of precision medicine, in its sale to Unchained Labs, a portfolio company of The Carlyle Group.

Other Representative M&A Matters

  • Feeney Utility Services Group in its sale to Artera Services, LLC, a Clayton, Dubilier & Rice portfolio company.
  • SiOnyx, an image sensor and camera company specializing in low light and near infrared imaging, in its sale to DC Capital Partners.
  • HouseWorks, a home health care provider, in connection with a majority equity investment by InTandem Capital Partners.
Read less

News & Press

Press Release Thumbnail Mintz

Mintz is pleased to have represented Boothby Therapy Services, New Hampshire’s leading provider of speech therapy, occupational therapy, school psychology, vision, orientation, and mobility, on its acquisition by Point Quest Group, a national provider of special education services, training, and program management. The Mintz deal team was led by Mergers & Acquisitions Practice Co-chair Dean Zioze and Associate Troy Nichols.

Press Release Thumbnail Mintz

Mintz is pleased to have represented Royal Philips, a global leader in health technology, in the sale of its Emergency Care business to Emergency Care Holdings, a platform backed by Bridgefield Capital. The Emergency Care business offers products that play a critical role in acute care management, both inside and outside the hospital, including cardiac resuscitation, such as automated external defibrillators, and emergency care devices for professional and consumer applications. Following the sale, the business now operates as Heartstream and continues to market select products under a brand license with Philips.

Press Release Thumbnail Mintz

BOSTON – Mintz represented HouseWorks, a leading home health care provider, in connection with a strategic investment from InTandem Capital, a healthcare services focused private equity firm.

Press Release Thumbnail Mintz

Mintz attorneys in Boston, New York, and Washington, DC, closed four Private Equity transactions in the past month. Along with acquisitions for Charlesbank Capital Partners, DIF Capital Partners portfolio company Joink LLC, and Artemis Capital Partners, the firm represented the CEO and some managers of Salary.com in the sale of most of the company’s equity interests to Accel-KKR.

Press Release Thumbnail Mintz

Mintz took lead role for long-term client NanoView Biosciences in its sale to Unchained Labs, a portfolio company of The Carlyle Group. NanoView, through its ExoView technology, characterizes exosomes and the company’s LentiView platform complements Unchained Labs’ tools for gene therapy researchers working with lentivirus, which is an immunodeficiency virus that causes AIDS.

News Thumbnail Mintz
Mintz Member Marc Mantell and Associate Scott Dunberg co-authored an article published in the May 2020 issue of Wolters Kluwer’s Insights: The Corporate and Securities Law Advisor that examined a potential increase in the use of earnouts in mergers and acquisitions, as dealmaking has sputtered in reaction to the coronavirus pandemic. Mintz Associate Troy Nichols also contributed to this article.
Read less